scholarly journals Enzymatically Degraded, Nonoxidized LDL Induces Human Vascular Smooth Muscle Cell Activation, Foam Cell Transformation, and Proliferation

Circulation ◽  
2000 ◽  
Vol 101 (15) ◽  
pp. 1799-1805 ◽  
Author(s):  
Mariam Klouche ◽  
Stefan Rose-John ◽  
Walther Schmiedt ◽  
Sucharit Bhakdi
1996 ◽  
Vol 271 (19) ◽  
pp. 11317-11324 ◽  
Author(s):  
Wee Soo Shin ◽  
Yi-Hui Hong ◽  
Hai-Bing Peng ◽  
Raffaele De Caterina ◽  
Peter Libby ◽  
...  

2007 ◽  
Vol 328 (1) ◽  
pp. 185-195 ◽  
Author(s):  
Claudia Boccardi ◽  
Antonella Cecchettini ◽  
Anna Caselli ◽  
Guido Camici ◽  
Monica Evangelista ◽  
...  

2020 ◽  
Vol 4 (3) ◽  
pp. 211-216
Author(s):  
Lutfu Askin ◽  
Okan Tanriverdi ◽  
Hakan Tibilli ◽  
Serdar Turkmen

The relationship between serum vaspin levels and metabolic or coronary artery disease is currently of interest for researchers. Although adipokine concentrations have been shown to be increased significantly in atherosclerotic lesions, the role adipokines in the atherosclerotic process remains to be elucidated. Vaspin is a new biological marker associated with obesity and impaired insulin sensitivity. Plasma vaspin concentration has been shown to correlate with the severity of coronary artery disease. Vascular inflammation triggered by vaspin inhibits atherogenesis by suppressing macrophage foam cell formation and vascular smooth muscle cell migration and proliferation. Vaspin also contributes to plaque stabilization by increasing collagen content and reducing the intraplaque macrophage to vascular smooth muscle cell ratio. The therapeutic goal concerning vaspin is to fight atherosclerosis and related diseases, as well as to maintain vascular health.


Sign in / Sign up

Export Citation Format

Share Document